Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.
Sonnenday
C J
CJ
Department of Surgery, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.
Ratner
L E
LE
Zachary
A A
AA
Burdick
J F
JF
Samaniego
M D
MD
Kraus
E
E
Warren
D S
DS
Montgomery
R A
RA
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D044469:Racial Groups; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014481:United States
D016756:Immunoglobulins, Intravenous; D007518:Isoantibodies; D003404:Creatinine; D016559:Tacrolimus